Tumor-derived TGM2 drives macrophage-mediated angiogenesis via the PKM2/STAT1/CCL2 axis in gastric cancer
Transglutaminase 2 (TGM2) has been implicated in the regulation of angiogenesis, but the underlying mechanisms remain largely elusive. This study aimed to systematically elucidate the functional role and molecular mechanisms through which tumor-derived TGM2 modulates angiogenesis in gastric cancer. Bioinformatics analysis and a combination of in vivo and in vitro assays were utilized to dissect the role and mechanisms of TGM2 in angiogenesis (e.g., xenograft tumor models, single-cell RNA sequencing, flow cytometry, mass spectrometry, Western blotting, and chromatin immunoprecipitation). Additionally, tumor-bearing mice were treated with Calcimycin to evaluate whether targeting TGM2 could regulate angiogenesis. CD31 was highly expressed in gastric cancer tissues and exhibited a significant positive correlation with TGM2 expression. In vivo, TGM2 promoted angiogenesis in murine subcutaneous tumors, a process accompanied by increased infiltration of VEGFA+ M2d macrophages. Mechanistic studies revealed that TGM2 enhanced the transcription and secretion of CCL2, thereby inducing macrophage polarization towards the VEGFA+ M2d subset. At the molecular level, GTP-bound TGM2 functioned as a protein kinase, promoting the phosphorylation and dimerization of pyruvate kinase M2 (PKM2). Dimerized PKM2 further mediated the phosphorylation and nuclear translocation of STAT1, ultimately driving CCL2 transcription. Targeting GTP-bound TGM2 with Calcimycin reversed the aforementioned pathway. Notably, tumor-bearing mice with high TGM2 expression showed greater sensitivity to Calcimycin treatment, as evidenced by reduced angiogenesis and inhibited M2d macrophage differentiation. This study uncovers a novel TGM2-PKM2/STAT1-CCL2 axis regulating M2d macrophage differentiation and angiogenesis in GC, establishing TGM2 as a promising therapeutic target and predictive biomarker.
Authors
- Yikai Shen (ORCID: https://orcid.org/0000-0002-0577-1408)
- Zetian Chen (ORCID: https://orcid.org/0009-0005-2948-6061)
- Lu Zhang (ORCID: https://orcid.org/0000-0002-2317-5204)
- Jianghao Xu (ORCID: https://orcid.org/0000-0001-5111-6386)
- Hongxin Huang (ORCID: https://orcid.org/0009-0006-8313-585X)
- Qingya Li
Institutions
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Cell Death and Disease
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1038/s41419-026-09459-6
- Primary Topic
- Angiogenesis and VEGF in Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00